FiercePharma

Actavis Announces FDA Approval of Expanded Label for BOTOX(R) (OnabotulinumtoxinA) for the Treatment of Upper Limb Spasticity in Adults

Label updates include addition of two thumb flexor muscles and increased maximum cumulative dose DUBLIN, April 20, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), which recently completed the ...
Monthly Prescribing Reference

Botox Label Expanded, Addition of Two Flexor Muscles

BOTOX (onabotulinumtoxin A) 50 Units, 100 Units, 200 Units per vial by Allergan The FDA has approved an expansion of the Botox (onabotulinumtoxinA; Actavis) label for the treatment of adults with ...
WebMD

Upper Limb Spasticity

What Is Upper Limb Spasticity? Upper limb spasticity is a condition that affects the way you move your arms. It makes your muscles stiff and flexed. Sometimes, your arms will twitch or move in a way ...
Nasdaq

FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity

-- BOTOX® has demonstrated efficacy and has an established safety profile with over 10 years of clinical use in adult upper limb spasticity NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ -- Allergan, ...
Healio

FDA approves Botox label expansion for adult upper limb spasticity

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a label expansion for Botox to include eight new muscles and the use of ultrasound for the ...
Monthly Prescribing Reference

Botox Approval Expanded to Include 8 New Muscles for Upper Limb Spasticity

The indication for adult upper limb spasticity treatment now includes elbow and forearm muscles, intrinsic hand muscles, and thumb muscles. The Food and Drug Administration (FDA) has expanded the ...